Ascend Vitality Review

What Ascend Vitality charges

• NAD+: $199 — TERM-GATED: printed as "NAD+ — Starting at $199/month — As low as with 6-month plan". The qualifier is quoted exactly because it is incomplete on the page; what it establishes is that the six-month plan is the condition for the figure
• NAD+: $149 — printed as "NAD+ Nasal Spray — Starting at $149/month — As low as with 6-month plan — NAD+ (900 mg or 1200 mg)". Two strengths share one figure, and the six-month condition applies as above
• Glutathione: $149 — printed as "Glutathione — Starting at $149/month — As low as with 6-month plan — Glutathione 2000 mg". The milligram strength is stated, which is unusual on this roster

Ascend Vitality also sells 3 compounds this site boards without publishing a price for them: BPC-157 (board ranks no provider), TB-500 (board ranks no provider) and GHK-Cu.

Stacks, named and itemised

Two of this seller's products are combinations sold under marketing names. Unusually, the card for each names the peptides inside it: one combines two tissue-repair peptides in a single vial, the other adds a copper peptide to the same pair.

Naming the constituents is the difference between a product a reader can evaluate and a blend they cannot. Several sellers on this roster sell named protocols and never say what is in them.

This roster carries no price row for either stack. A combination figure filed against one compound would appear on that compound's board as though it were the cost of that compound alone, and it is not.

The three compounds are declared on the row, because this seller genuinely sells them, and the figures stay in prose where the combination can be described.

An incomplete sentence is the only qualifier

Every card on the peptide page reads: product name, starting at, a figure with a month attached, and then the words as low as with six-month plan. The sentence is not finished. Something is missing between as low as and with.

What it establishes is still clear enough to act on: the six-month plan is the condition attached to the figure printed. A reader who does not commit to six months is not being quoted.

This site quotes the fragment rather than repairing it. Repairing it would mean writing a sentence the seller did not write and attributing it to them.

Every figure on the row is recorded as one that is not a monthly rate for that reason.

Strengths and formats stated

The nasal spray card names both available strengths. The antioxidant card names its milligram content. The injectable coenzyme is priced separately from the spray at a higher figure.

Publishing a strength beside a figure is rare enough on this roster to be worth crediting on its own, and it is the only way two sellers' prices for the same compound can be compared with any rigour.

The nasal spray and the injection being priced separately is the correct treatment of a route difference, and this roster carries them as separate rows with the route recorded.

A promotional banner was live on the site when this was checked, so the figures read here are discounted ones and will move when it ends.

Entity clear, testing claimed

The operating company is named in the footer with a street address, in both punctuations, alongside a copyright line. There is no vendor's name standing in for it.

Screened by that entity and by the brand against the regulator's warning-letter index, nothing returns.

The terms refer to a third-party lab and to laboratory testing. No certificate, PDF or index is reachable, so it is recorded as a claim rather than as testing.

No dispensing pharmacy is named and no state coverage list is published.

How we verified this

• Loaded the peptide catalogue and the about page with a full browser user-agent, printing the effective URL beside the requested one on both.
• Ran a nonsense-path control on the host in the same run, which returned a not-found status.
• Joined the page's text nodes before matching any figure, so a price split across elements could not read as an absence.
• Quoted the incomplete qualifier exactly as printed rather than repairing it into a sentence the seller did not write.
• Recorded every figure as one that is not a monthly rate, because the six-month plan is the stated condition on each.
• Declined to create a price row for either multi-peptide stack, and recorded the constituent compounds on the row instead.
• Recorded the strengths and the routes printed on each card in the dose field of the corresponding price row.
• Screened the operating company and the brand against the regulator's warning-letter index, with a nonsense query as a control in the same run.